만성 완전폐색 중재시술 기기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Chronic Total Occlusion Devices Market - Scope of Report

TMR's report on the global Chronic Total Occlusion Devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Chronic Total Occlusion Devices market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Chronic Total Occlusion Devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Chronic Total Occlusion Devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Chronic Total Occlusion Devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Chronic Total Occlusion Devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Chronic Total Occlusion Devices market.

The report delves into the competitive landscape of the global Chronic Total Occlusion Devices market. Key players operating in the global Chronic Total Occlusion Devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Chronic Total Occlusion Devices market profiled in this report.

Key Questions Answered in Global Chronic Total Occlusion Devices Market Report:

• What is the sales/revenue generated by Chronic Total Occlusion Devices across all regions during the forecast period?
• What are the opportunities in the global Chronic Total Occlusion Devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Chronic Total Occlusion Devices Market - Research Objectives and Research Approach

The comprehensive report on the global Chronic Total Occlusion Devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Chronic Total Occlusion Devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Chronic Total Occlusion Devices market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chronic Total Occlusion Devices Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Definition
  • 4.1.2. Industry Evolution /Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Sales Analysis of Major Micro Catheter Brands, 2022
• 5.2. Sales Analysis of Major Guide Wires Brands, 2022
• 5.3. Sales Analysis of Major Crossing Device Brands, 2022
• 5.4. Technological Advancements
• 5.5. Disease Prevalence & Incidence Rate globally with key countries
• 5.6. Regulatory Scenario by Region/globally
• 5.7. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product Type, 2017-2031
  • 6.3.1. Microcatheters
  • 6.3.2. Guidewires
  • 6.3.3. Balloon Catheters
  • 6.3.4. Crossing Devices
  • 6.3.5. Stents
  • 6.3.6. Others
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by End-user, 2017-2031
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. Market Attractiveness Analysis, by End-user

8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region

• 8.1. Key Findings
• 8.2. Market Value Forecast, by Region
  • 8.2.1. North America
  • 8.2.2. Europe
  • 8.2.3. Asia Pacific
  • 8.2.4. Latin America
  • 8.2.5. Middle East & Africa
• 8.3. Market Attractiveness Analysis, by Region

9. North America Chronic Total Occlusion Devices Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Key Findings
• 9.2. Market Value Forecast, by Product Type, 2017-2031
  • 9.2.1. Microcatheters
  • 9.2.2. Guidewires
  • 9.2.3. Balloon Catheters
  • 9.2.4. Crossing Devices
  • 9.2.5. Stents
  • 9.2.6. Others
• 9.3. Market Value Forecast, by End-user, 2017-2031
  • 9.3.1. Hospitals
  • 9.3.2. Ambulatory Surgical Centers
  • 9.3.3. Others
• 9.4. Market Value Forecast, by Country, 2017-2031
  • 9.4.1. U.S.
  • 9.4.2. Canada
• 9.5. Market Attractiveness Analysis
  • 9.5.1. By Product Type
  • 9.5.2. By End-user
  • 9.5.3. By Country

10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product Type, 2017-2031
  • 10.2.1. Microcatheters
  • 10.2.2. Guidewires
  • 10.2.3. Balloon Catheters
  • 10.2.4. Crossing Devices
  • 10.2.5. Stents
  • 10.2.6. Others
• 10.3. Market Value Forecast, by End-user, 2017-2031
  • 10.3.1. Hospitals
  • 10.3.2. Ambulatory Surgical Centers
  • 10.3.3. Others
• 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 10.4.1. Germany
  • 10.4.2. U.K.
  • 10.4.3. France
  • 10.4.4. Spain
  • 10.4.5. Italy
  • 10.4.6. Rest of Europe
• 10.5. Market Attractiveness Analysis
  • 10.5.1. By Product Type
  • 10.5.2. By End-user
  • 10.5.3. By Country/Sub-region

11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2017-2031
  • 11.2.1. Microcatheters
  • 11.2.2. Guidewires
  • 11.2.3. Balloon Catheters
  • 11.2.4. Crossing Devices
  • 11.2.5. Stents
  • 11.2.6. Others
• 11.3. Market Value Forecast, by End-user, 2017-2031
  • 11.3.1. Hospitals
  • 11.3.2. Ambulatory Surgical Centers
  • 11.3.3. Others
• 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.4.1. China
  • 11.4.2. Japan
  • 11.4.3. India
  • 11.4.4. Australia & New Zealand
  • 11.4.5. Rest of Asia Pacific
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Product Type
  • 11.5.2. By End-user
  • 11.5.3. By Country/Sub-region

12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2017-2031
  • 12.2.1. Microcatheters
  • 12.2.2. Guidewires
  • 12.2.3. Balloon Catheters
  • 12.2.4. Crossing Devices
  • 12.2.5. Stents
  • 12.2.6. Others
• 12.3. Market Value Forecast, by End-user, 2017-2031
  • 12.3.1. Hospitals
  • 12.3.2. Ambulatory Surgical Centers
  • 12.3.3. Others
• 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.4.1. Brazil
  • 12.4.2. Mexico
  • 12.4.3. Rest of Latin America
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Product Type
  • 12.5.2. By End-user
  • 12.5.3. By Country/Sub-region

13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2017-2031
  • 13.2.1. Microcatheters
  • 13.2.2. Guidewires
  • 13.2.3. Balloon Catheters
  • 13.2.4. Crossing Devices
  • 13.2.5. Stents
  • 13.2.6. Others
• 13.3. Market Value Forecast, by End-user, 2017-2031
  • 13.3.1. Hospitals
  • 13.3.2. Ambulatory Surgical Centers
  • 13.3.3. Others
• 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.4.1. GCC Countries
  • 13.4.2. South Africa
  • 13.4.3. Rest of Middle East & Africa
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Product Type
  • 13.5.2. By End-user
  • 13.5.3. By Country/Sub-region

14. Competition Landscape

• 14.1. Market Player - Competition Matrix (by tier and size of companies)
• 14.2. Market Share Analysis, by Company, 2022
• 14.3. Company Profiles
  • 14.3.1. Medtronic
    • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.1.2. Product Type Portfolio
    • 14.3.1.3. Financial Overview
    • 14.3.1.4. SWOT Analysis
    • 14.3.1.5. Strategic Overview
  • 14.3.2. Boston Scientific Corporation
    • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.2.2. Product Type Portfolio
    • 14.3.2.3. Financial Overview
    • 14.3.2.4. SWOT Analysis
    • 14.3.2.5. Strategic Overview
  • 14.3.3. Abbott
    • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.3.2. Product Type Portfolio
    • 14.3.3.3. Financial Overview
    • 14.3.3.4. SWOT Analysis
    • 14.3.3.5. Strategic Overview
  • 14.3.4. Asahi Intecc Co., Ltd
    • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.4.2. Product Type Portfolio
    • 14.3.4.3. Financial Overview
    • 14.3.4.4. SWOT Analysis
    • 14.3.4.5. Strategic Overview
  • 14.3.5. Acrostak Int. Distr. Sarl
    • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.5.2. Product Type Portfolio
    • 14.3.5.3. Financial Overview
    • 14.3.5.4. SWOT Analysis
    • 14.3.5.5. Strategic Overview
  • 14.3.6. Cook Medical
    • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.6.2. Product Type Portfolio
    • 14.3.6.3. Financial Overview
    • 14.3.6.4. SWOT Analysis
    • 14.3.6.5. Strategic Overview
  • 14.3.7. Koninklijke Philips N.V
    • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.7.2. Product Type Portfolio
    • 14.3.7.3. Financial Overview
    • 14.3.7.4. SWOT Analysis
    • 14.3.7.5. Strategic Overview
  • 14.3.8. Terumo Corporation
    • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.8.2. Product Type Portfolio
    • 14.3.8.3. Financial Overview
    • 14.3.8.4. SWOT Analysis
    • 14.3.8.5. Strategic Overview
  • 14.3.9. Teleflex Incorporated
    • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.9.2. Product Type Portfolio
    • 14.3.9.3. Financial Overview
    • 14.3.9.4. SWOT Analysis
    • 14.3.9.5. Strategic Overview
  • 14.3.10. Becton, Dickinson and Company
    • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.10.2. Product Type Portfolio
    • 14.3.10.3. Financial Overview
    • 14.3.10.4. SWOT Analysis
    • 14.3.10.5. Strategic Overview
  • 14.3.11. Reflow Medical, Inc.
    • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.11.2. Product Type Portfolio
    • 14.3.11.3. Financial Overview
    • 14.3.11.4. SWOT Analysis
    • 14.3.11.5. Strategic Overview
  • 14.3.12. Cordis
    • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.12.2. Product Type Portfolio
    • 14.3.12.3. Financial Overview
    • 14.3.12.4. SWOT Analysis
    • 14.3.12.5. Strategic Overview